Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.20.1
Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenues:    
Total revenues $ 3,115,593 $ 2,472,517
Cost of revenues 917,336 886,481
Research and development costs 829,528 584,540
Sales and marketing expenses 1,298,594 1,040,712
General and administrative expenses 1,278,509 933,033
Operating loss (1,208,374) (972,249)
Other income (expense):    
Other income (expense), net (33,304) 5,629
Interest expense, net (813,147) (254,105)
Net loss $ (2,054,825) $ (1,220,725)
Net loss per share attributable to common stockholders:    
Basic and diluted (in dollars per share) $ (0.13) $ (0.11)
Weighted average shares outstanding:    
Basic and diluted (in shares) 15,438,276 11,044,125
Product Revenue    
Revenues:    
Total revenues $ 2,103,384 $ 2,163,953
Service and Other Revenues    
Revenues:    
Total revenues $ 1,012,209 $ 308,564